Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ylä-Herttuala

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Herz|October 1, 1992
Gene expression in atherosclerotic lesionsS Ylä-Herttuala
Current Opinion in Lipidology|October 1, 1996
Expression of lipoprotein receptors and related molecules in atherosclerotic lesionsS Ylä-Herttuala
Current Opinion in Lipidology|April 1, 1997
Vascular gene transferS Ylä-Herttuala
Acta Medica Scandinavica. Supplementum|January 1, 1985
Development of atherosclerotic plaquesS Ylä-Herttuala
Annals of the New York Academy of Sciences|July 23, 1999
Oxidized LDL and atherogenesisS Ylä-Herttuala
Annals of Medicine|April 1, 1996
Gene therapy for cardiovascular diseasesS Ylä-Herttuala
Annals of Medicine|January 1, 1991
Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosisS Ylä-Herttuala
Current Opinion in Lipidology|September 18, 1998
Is oxidized low-density lipoprotein present in vivo?S Ylä-Herttuala
Drugs of Today (Barcelona, Spain : 1998)|July 9, 2003
Gene therapy for the treatment of peripheral vascular disease and coronary artery diseaseM Hedman, S Ylä-Herttuala
Current Atherosclerosis Reports|December 21, 2000
Gene therapy for atherosclerosis and atherosclerosis-related diseasesT Pakkanen, S Ylä-Herttuala
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Herz|October 1, 1992
Gene expression in atherosclerotic lesionsS Ylä-Herttuala
Current Opinion in Lipidology|October 1, 1996
Expression of lipoprotein receptors and related molecules in atherosclerotic lesionsS Ylä-Herttuala
Current Opinion in Lipidology|April 1, 1997
Vascular gene transferS Ylä-Herttuala
Acta Medica Scandinavica. Supplementum|January 1, 1985
Development of atherosclerotic plaquesS Ylä-Herttuala
Annals of the New York Academy of Sciences|July 23, 1999
Oxidized LDL and atherogenesisS Ylä-Herttuala
Annals of Medicine|April 1, 1996
Gene therapy for cardiovascular diseasesS Ylä-Herttuala
Annals of Medicine|January 1, 1991
Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosisS Ylä-Herttuala
Current Opinion in Lipidology|September 18, 1998
Is oxidized low-density lipoprotein present in vivo?S Ylä-Herttuala
Drugs of Today (Barcelona, Spain : 1998)|July 9, 2003
Gene therapy for the treatment of peripheral vascular disease and coronary artery diseaseM Hedman, S Ylä-Herttuala
Current Atherosclerosis Reports|December 21, 2000
Gene therapy for atherosclerosis and atherosclerosis-related diseasesT Pakkanen, S Ylä-Herttuala
Pageof 18